Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
30.73
+1.30 (4.42%)
At close: Mar 9, 2026, 4:00 PM EDT
30.61
-0.12 (-0.39%)
After-hours: Mar 9, 2026, 5:15 PM EDT

Celldex Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
2,0461,8051,6772,1692,0991,803
Upgrade
Market Cap Growth
36.49%7.65%-22.71%3.32%16.42%160.10%
Upgrade
Enterprise Value
1,5521,2249241,9361,7791,383
Upgrade
Last Close Price
29.4327.1625.2739.6644.5738.64
Upgrade
PS Ratio
1338.651168.13238.82315.12890.64387.68
Upgrade
PB Ratio
3.723.422.245.056.444.30
Upgrade
P/TBV Ratio
4.143.612.335.407.024.60
Upgrade
EV/Sales Ratio
1004.52792.34131.57281.34754.94297.37
Upgrade
Debt / Equity Ratio
0.000.000.010.010.010.01
Upgrade
Net Debt / Equity Ratio
-0.98-0.98-0.97-0.98-0.92-0.97
Upgrade
Net Debt / EBITDA Ratio
1.821.823.763.032.896.13
Upgrade
Net Debt / FCF Ratio
2.422.424.523.862.856.52
Upgrade
Asset Turnover
0.000.000.010.020.010.01
Upgrade
Quick Ratio
10.2110.2118.3813.6916.4124.71
Upgrade
Current Ratio
10.4910.4918.9213.8717.0724.86
Upgrade
Return on Equity (ROE)
-40.62%-40.62%-26.84%-37.45%-30.13%-22.43%
Upgrade
Return on Assets (ROA)
-26.12%-26.12%-19.38%-21.70%-16.79%-12.70%
Upgrade
Return on Capital Employed (ROCE)
-54.00%-54.00%-25.90%-32.70%-32.10%-16.20%
Upgrade
Earnings Yield
-12.51%-14.34%-9.42%-6.52%-5.35%-3.91%
Upgrade
FCF Yield
-10.33%-11.84%-9.53%-5.03%-5.03%-3.45%
Upgrade
Buyback Yield / Dilution
-3.15%-3.15%-32.91%-3.33%-9.37%-44.64%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.